Board Meeting3 Nov 2026, 01:45 pm
Biofil Chemicals Board Meeting on Nov 14 to Approve Unaudited Results
AI Summary
Biofil Chemicals & Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda is to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. Following the declaration of these results, the trading window for dealing in the company's securities will reopen 48 hours later for designated persons and connected individuals, as per SEBI regulations.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- Agenda includes approval of unaudited financial results.
- Results for the quarter and half-year ended September 30, 2026.
- Trading window to reopen 48 hours after results declaration.
Price Impact
More from BIOFILCHEM